Aquatic Capital Management LLC Takes Position in McKesson Corporation $MCK

Key Points

• Aquatic Capital Management LLC initiated a new position in McKesson, buying 22,368 shares (~$17.28M) in Q3, while other large institutions (Vanguard, Franklin, AllianceBernstein, Norges Bank, Boston Partners) also increased stakes, leaving institutional ownership at about 85.07%.
• Insiders have been net sellers recently: the CAO sold 328 shares and EVP Michele Lau sold 2,725 shares (a 45.63% reduction), with insiders disposing of 3,868 shares worth $3.74M over the past three months and owning just 0.08% of the stock.
• Fundamentals and payouts: McKesson beat quarterly EPS estimates ($9.34 vs. $9.19) on $106.16B revenue (up 11.4% y/y), set FY2026 guidance at $38.80–39.20 EPS, announced a $0.82 quarterly dividend ($3.28 annual, ~0.3% yield), and the stock trades near $941.51 with a 12‑month range of $637–$999.

Aquatic Capital Management LLC purchased a new position in McKesson Corporation (NYSE:MCK - Free Report) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 22,368 shares of the company's stock, valued at approximately $17,280,000.

Several other large investors also recently modified their holdings of MCK. Vanguard Group Inc. lifted its holdings in McKesson by 2.0% in the second quarter. Vanguard Group Inc. now owns 12,072,090 shares of the company's stock valued at $8,846,186,000 after acquiring an additional 232,286 shares during the period. Franklin Resources Inc. boosted its position in McKesson by 3.5% in the third quarter. Franklin Resources Inc. now owns 2,681,321 shares of the company's stock worth $2,071,428,000 after purchasing an additional 90,948 shares during the last quarter. Alliancebernstein L.P. grew its stake in shares of McKesson by 5.6% during the 3rd quarter. Alliancebernstein L.P. now owns 2,394,699 shares of the company's stock valued at $1,850,001,000 after purchasing an additional 126,684 shares during the period. Norges Bank purchased a new stake in shares of McKesson during the 2nd quarter valued at about $1,346,661,000. Finally, Boston Partners increased its position in shares of McKesson by 6.7% during the 3rd quarter. Boston Partners now owns 1,330,953 shares of the company's stock valued at $1,027,569,000 after purchasing an additional 83,357 shares during the last quarter. Institutional investors own 85.07% of the company's stock.

Insiders Place Their Bets

In other news, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the company's stock in a transaction dated Friday, February 6th. The stock was sold at an average price of $955.00, for a total value of $313,240.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Michele Lau sold 2,725 shares of the stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $990.00, for a total value of $2,697,750.00. Following the sale, the executive vice president owned 3,247 shares of the company's stock, valued at $3,214,530. This represents a 45.63% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 3,868 shares of company stock worth $3,743,820 in the last three months. 0.08% of the stock is owned by company insiders.

McKesson Trading Down 0.3%

NYSE MCK opened at $941.51 on Friday. McKesson Corporation has a 12 month low of $637.00 and a 12 month high of $999.00. The stock has a market cap of $115.32 billion, a price-to-earnings ratio of 27.08, a PEG ratio of 1.51 and a beta of 0.38. The company's 50 day moving average is $893.90 and its two-hundred day moving average is $825.35.

McKesson (NYSE:MCK - Get Free Report) last posted its quarterly earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share for the quarter, topping analysts' consensus estimates of $9.19 by $0.15. The business had revenue of $106.16 billion during the quarter, compared to analyst estimates of $105.98 billion. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. The company's revenue was up 11.4% on a year-over-year basis. During the same period in the prior year, the business posted $8.03 earnings per share. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. Sell-side analysts forecast that McKesson Corporation will post 32.77 EPS for the current year.

McKesson Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, April 1st. Investors of record on Monday, March 2nd will be issued a $0.82 dividend. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $3.28 annualized dividend and a yield of 0.3%. McKesson's dividend payout ratio is currently 9.43%.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on MCK shares. Wall Street Zen downgraded shares of McKesson from a "buy" rating to a "hold" rating in a report on Saturday. Morgan Stanley reiterated an "overweight" rating and issued a $966.00 price target on shares of McKesson in a research report on Thursday, January 29th. Barclays boosted their price objective on shares of McKesson from $960.00 to $1,050.00 and gave the company an "overweight" rating in a research report on Wednesday, February 18th. Mizuho upped their price objective on McKesson from $880.00 to $885.00 and gave the stock a "neutral" rating in a research note on Thursday, February 5th. Finally, Raymond James Financial set a $970.00 target price on McKesson in a report on Thursday, March 5th. Thirteen investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $960.93.

McKesson Company Profile

McKesson Corporation NYSE: MCK is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company's core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.